166 related articles for article (PubMed ID: 29439904)
21. Benzoxazolinone aryl sulfonamides as potent, selective Na
Pero JE; Rossi MA; Lehman HDGF; Kelly MJ; Mulhearn JJ; Wolkenberg SE; Cato MJ; Clements MK; Daley CJ; Filzen T; Finger EN; Gregan Y; Henze DA; Jovanovska A; Klein R; Kraus RL; Li Y; Liang A; Majercak JM; Panigel J; Urban MO; Wang J; Wang YH; Houghton AK; Layton ME
Bioorg Med Chem Lett; 2017 Jun; 27(12):2683-2688. PubMed ID: 28465103
[TBL] [Abstract][Full Text] [Related]
22. Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core.
Wang JT; Zheng YM; Chen YT; Gu M; Gao ZB; Nan FJ
Acta Pharmacol Sin; 2020 Mar; 41(3):293-302. PubMed ID: 31316182
[TBL] [Abstract][Full Text] [Related]
23. Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1.
Murray JK; Biswas K; Holder JR; Zou A; Ligutti J; Liu D; Poppe L; Andrews KL; Lin FF; Meng SY; Moyer BD; McDonough SI; Miranda LP
Bioorg Med Chem Lett; 2015 Nov; 25(21):4866-4871. PubMed ID: 26112439
[TBL] [Abstract][Full Text] [Related]
24. Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na
Sun S; Jia Q; Zenova AY; Wilson MS; Chowdhury S; Focken T; Li J; Decker S; Grimwood ME; Andrez JC; Hemeon I; Sheng T; Chen CA; White A; Hackos DH; Deng L; Bankar G; Khakh K; Chang E; Kwan R; Lin S; Nelkenbrecher K; Sellers BD; DiPasquale AG; Chang J; Pang J; Sojo L; Lindgren A; Waldbrook M; Xie Z; Young C; Johnson JP; Robinette CL; Cohen CJ; Safina BS; Sutherlin DP; Ortwine DF; Dehnhardt CM
J Med Chem; 2019 Jan; 62(2):908-927. PubMed ID: 30499663
[TBL] [Abstract][Full Text] [Related]
25. The discovery and optimization of benzimidazoles as selective Na
Brown AD; Bagal SK; Blackwell P; Blakemore DC; Brown B; Bungay PJ; Corless M; Crawforth J; Fengas D; Fenwick DR; Gray V; Kemp M; Klute W; Malet Sanz L; Miller D; Murata Y; Payne CE; Skerratt S; Stevens EB; Warmus JS
Bioorg Med Chem; 2019 Jan; 27(1):230-239. PubMed ID: 30538065
[TBL] [Abstract][Full Text] [Related]
26. Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na
Luo G; Chen L; Easton A; Newton A; Bourin C; Shields E; Mosure K; Soars MG; Knox RJ; Matchett M; Pieschl RL; Post-Munson DJ; Wang S; Herrington J; Graef J; Newberry K; Sivarao DV; Senapati A; Bristow LJ; Meanwell NA; Thompson LA; Dzierba C
J Med Chem; 2019 Jan; 62(2):831-856. PubMed ID: 30576602
[TBL] [Abstract][Full Text] [Related]
27. Na
McKerrall SJ; Sutherlin DP
Bioorg Med Chem Lett; 2018 Oct; 28(19):3141-3149. PubMed ID: 30139550
[TBL] [Abstract][Full Text] [Related]
28. Discovery of pyridyl urea sulfonamide inhibitors of Na
Butler JR; Rescourio G; Milgram BC; Foti RS; Kornecook T; Ligutti J; Moyer BD; Taborn K; Youngblood BD; Yu V; Shimanovich R; Boezio A; Weiss M
Bioorg Med Chem Lett; 2022 Oct; 73():128892. PubMed ID: 35850422
[TBL] [Abstract][Full Text] [Related]
29. Discovery of DS-1971a, a Potent, Selective Na
Shinozuka T; Kobayashi H; Suzuki S; Tanaka K; Karanjule N; Hayashi N; Tsuda T; Tokumaru E; Inoue M; Ueda K; Kimoto H; Domon Y; Takahashi S; Kubota K; Yokoyama T; Shimizugawa A; Koishi R; Fujiwara C; Asano D; Sakakura T; Takasuna K; Abe Y; Watanabe T; Kitano Y
J Med Chem; 2020 Sep; 63(18):10204-10220. PubMed ID: 32392056
[TBL] [Abstract][Full Text] [Related]
30. Molecular determinants for ligand binding at Nav1.4 and Nav1.7 channels: Experimental affinity results analyzed by molecular modeling.
Kong DJ; Wang Y; Wang HX; Wang MX; Wang J; Cheng MS
Comput Biol Chem; 2019 Dec; 83():107132. PubMed ID: 31563636
[TBL] [Abstract][Full Text] [Related]
31. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
Theile JW; Fuller MD; Chapman ML
Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
[TBL] [Abstract][Full Text] [Related]
32. Discovery of new indole-based acylsulfonamide Na
Wu YJ; Venables B; Guernon J; Chen J; Sit SY; Rajamani R; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2019 Feb; 29(4):659-663. PubMed ID: 30638874
[TBL] [Abstract][Full Text] [Related]
33. Structure and activity relationship in the (S)-N-chroman-3-ylcarboxamide series of voltage-gated sodium channel blockers.
Kers I; Csjernyik G; Macsari I; Nylöf M; Sandberg L; Skogholm K; Bueters T; Eriksson AB; Oerther S; Lund PE; Venyike E; Nyström JE; Besidski Y
Bioorg Med Chem Lett; 2012 Sep; 22(17):5618-24. PubMed ID: 22832315
[TBL] [Abstract][Full Text] [Related]
34. Highly potent and selective Na
Storer RI; Pike A; Swain NA; Alexandrou AJ; Bechle BM; Blakemore DC; Brown AD; Castle NA; Corbett MS; Flanagan NJ; Fengas D; Johnson MS; Jones LH; Marron BE; Payne CE; Printzenhoff D; Rawson DJ; Rose CR; Ryckmans T; Sun J; Theile JW; Torella R; Tseng E; Warmus JS
Bioorg Med Chem Lett; 2017 Nov; 27(21):4805-4811. PubMed ID: 29029933
[TBL] [Abstract][Full Text] [Related]
35. New aryl and acylsulfonamides as state-dependent inhibitors of Na
Zidar N; Tomašič T; Kikelj D; Durcik M; Tytgat J; Peigneur S; Rogers M; Haworth A; Kirby RW
Eur J Med Chem; 2023 Oct; 258():115530. PubMed ID: 37329714
[TBL] [Abstract][Full Text] [Related]
36. Discovery of pyrrolo-benzo-1,4-diazines as potent Na(v)1.7 sodium channel blockers.
Ho GD; Tulshian D; Bercovici A; Tan Z; Hanisak J; Brumfield S; Matasi J; Heap CR; Earley WG; Courneya B; Herr RJ; Zhou X; Bridal T; Rindgen D; Sorota S; Yang SW
Bioorg Med Chem Lett; 2014 Sep; 24(17):4110-3. PubMed ID: 25113934
[TBL] [Abstract][Full Text] [Related]
37. Identification of aryl sulfonamides as novel and potent inhibitors of Na
Sun S; Jia Q; Zenova AY; Lin S; Hussainkhel A; Mezeyova J; Chang E; Goodchild SJ; Xie Z; Lindgren A; de Boer G; Kwan R; Khakh K; Sojo L; Bichler P; Johnson JP; Empfield JR; Cohen CJ; Dehnhardt CM; Dean R
Bioorg Med Chem Lett; 2021 Aug; 45():128133. PubMed ID: 34044121
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Tarantula Venom-Derived Na
Wu B; Murray JK; Andrews KL; Sham K; Long J; Aral J; Ligutti J; Amagasu S; Liu D; Zou A; Min X; Wang Z; Ilch CP; Kornecook TJ; Lin MJ; Be X; Miranda LP; Moyer BD; Biswas K
J Med Chem; 2018 Nov; 61(21):9500-9512. PubMed ID: 30346167
[TBL] [Abstract][Full Text] [Related]
39. Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor.
Flinspach M; Xu Q; Piekarz AD; Fellows R; Hagan R; Gibbs A; Liu Y; Neff RA; Freedman J; Eckert WA; Zhou M; Bonesteel R; Pennington MW; Eddinger KA; Yaksh TL; Hunter M; Swanson RV; Wickenden AD
Sci Rep; 2017 Jan; 7():39662. PubMed ID: 28045073
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic Ligation of a Pore Blocker Toxin and a Gating Modifier Toxin: Creating Double-Knotted Peptides with Improved Sodium Channel Na
Tran HNT; Tran P; Deuis JR; Agwa AJ; Zhang AH; Vetter I; Schroeder CI
Bioconjug Chem; 2020 Jan; 31(1):64-73. PubMed ID: 31790574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
